Print
PDF

The Lynne Cohen and Norma Livingston Preventive Care Program for Women's Cancers at University of Alabama, Birmingham

 

Program

In this clinic, we provide an in-depth consultation examining personal and family medical history. With all of the information, our team will collaborate to develop an individual risk assessment, educate each individual about their risk and determine the best early detection and risk-reduction strategies on an individual basis. Women at high risk for ovarian and breast cancer have access to screening services, such as mammography, MRI, pelvic ultrasounds and serum-based screening tests as indicated; consultation with a genetic counselor who has specific expertise in ovarian and breast cancer genetics; breast examinations; recommendations for risk-reduction strategies including lifestyle modification, chemo-preventive medications that have been found to decrease breast or ovarian cancer risk and prophylactic surgery if indicated; as well as access to the latest early detection and prevention clinical trials.

Studies Open to Participants

  1. UAB 0413: A Phase III Randomized Study of Exemestane vs. Placebo in Postmenopausal Women at Increased Risk of Developing Breast Cancer
  2. Ovarian Spore Project: Array-based analysis of primary and metastatic ovarian tumors to identify risk factors/predisposing genetic elements for ovarian cancer, as well as genetic heterogeneity associated with ovarian cancer spread and progression.
  3. Add Lynne Cohen Registry. Text to come.

Directors

Dr. Helen Krontiras, Breast Surgical Oncologist
Dr. Mack Barnes, Gynecologic Oncologist

Eligibility

Personal or family history of ovarian/breast cancer; BRCA 1 or 2 and/or Ashkenazi Jewish descent with one affected relative; personal risk factors that may increase risk for breast cancer including breast biopsy with atypical cells or lobular carcinoma in situ, multiple breast biopsies, age greater than 60, hormone related factors including beginning menstrual periods at an early age, going through menopause at a late age, and/or having no children or having a first child after age 30

Phone

866.494.5778